Commitments and Contingencies - Joint Venture - Income Statement Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Long term purchase commitment
Loss before income tax	$ (9,368)	$ (12,397)
Income tax expense	0	0
Net loss	(9,368)	(12,397)
Net loss attributable to the Company	(9,226)	$ (12,202)
Magdalena Biosciences, Inc.
Long term purchase commitment
Operating expenses	(40)
Loss before income tax	(40)
Income tax expense	0
Net loss	(40)
Net loss attributable to the Company	$ (16)